Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.
Multiple types of oncolytic viruses are currently under investigation in clinical trials. To optimize therapeutic outcomes it is believed that the plethora of different tumor types will require a diversity of different virus types. Sendai virus (SeV), a murine parainfluenza virus, displays a broad h...
Guardado en:
Autores principales: | Martina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, Johanna Lampe, Irina Smirnow, Andrea Schenk, Sebastian Lange, Thomas S Weiss, Wolfgang Neubert, Ulrich M Lauer, Michael Bitzer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbf8a5eb3e6e4abe89c1df655bd5ca3a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Oncolytic Virotherapy
-
Oncolytic Virotherapy
Publicado: (2016) -
Oncolytic Virotherapy: From Bench to Bedside
por: Ludi Yang, et al.
Publicado: (2021) -
ITC Sendai 2019 Special Issue: Part 1 – Papers from ITC Sendai 2019 –
por: Kazuo Hokkirigawa
Publicado: (2019) -
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
por: D. G. Roy, et al.
Publicado: (2021)